Metabolism and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in humans. [electronic resource]
Producer: 20100602Description: 474-83 p. digitalISSN:- 1521-009X
- Adolescent
- Adult
- Anticholesteremic Agents -- adverse effects
- Biotransformation
- Cholesterol Ester Transfer Proteins -- antagonists & inhibitors
- Cytochrome P-450 CYP3A -- genetics
- Cytochrome P-450 CYP3A Inhibitors
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme System -- genetics
- Feces -- chemistry
- Humans
- Isoenzymes -- antagonists & inhibitors
- Male
- Microsomes, Liver -- enzymology
- Middle Aged
- Molecular Structure
- Oxazolidinones -- adverse effects
- Recombinant Proteins -- antagonists & inhibitors
- Tandem Mass Spectrometry
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.